The IPO of the year, the biggest one, uh, popping on its open last hours, just a few minutes ago, really after some middling performance in the IPO market generally. Is it a sign of pent-up demand into mega offerings like SpaceX next year. A sigh of relief for the private equity space, too.Leslie Picker has more over at the NASDAQ. Leslie, hey, Kelly, [music] yes. The largest IPO of the year, Medline, opening for trading about 15 minutes ago at $35 per share.That's up more than 20% from its IPO price of $29 ...

ToplineMedical supply firm Medline’s stock price rose around 29% on Wednesday after debuting on the Nasdaq, after raising $6.26 billion on Tuesday for the largest initial public offering of the year.Medline CEO Jim Boyle speaks before ringing the opening bell at the Nasdaq on Wednesday.Getty Images ...

Key Takeaways Shares of medical supply company Medline soared in their trading debut on the Nasdaq Wednesday.The company raised more than $6 billion with the sale of 216 million shares priced at $29 each, making its the largest U.S. IPO in terms of proceeds since Rivian's in 2021. Medline shares surged in their trading debut Wednesday, after the medical supply company raised $6.26 billion in one of the biggest initial public offerings in recent years.  The stock, which trades under the "MDLN" stock tic ...

Medline shares began trading under the ticker 'MDLN' Wednesday in the biggest IPO since 2021. ...

About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...

Shares of Medline opened 20.7% above their offer price in their Nasdaq debut on Wednesday, giving the medical supply giant a valuation of $46.03 billion. ...

Key Takeaways Medical supply company Medline is set to make its trading debut on the Nasdaq today.The company raised more than $6 billion with the sale of 216 million shares priced at $29 each, making its the largest U.S. IPO in terms of proceeds since Rivian's in 2021. Medline is set to start trading on the Nasdaq today, after the medical supply company raised $6.26 billion in one of the biggest initial public offerings in recent years.  The medical supply giant, which will debut under the "MDLN" stoc ...

"Historically, we've done very little advertising, very little marketing, and this gives us a way to amplify our voice and actually expand really the receptivity of who we are," Medline CEO Jim Boyle told CNBC's "Squawk Box" earlier Wednesday. "We are the largest company you've never heard of, and we happen to be everywhere. And that's a really interesting thing." U.S. medical supplies giant Medline is set to debut on the Nasdaq on Wednesday after the biggest initial public offering of the year. The private ...

It's been a tumultuous year for U.S. stock markets. Investors have had their nerves rattled twice this year by government-related events—President Trump's Liberation Day tariffs in the spring, followed by the longest U.S. government shutdown in history this fall. That's on top of an economy already hit hard by inflation and declining consumer confidence. Yet despite this, there have still been several high-profile and successful initial public offerings throughout the year—especially in the AI and fintech s ...

Medline stock made a blockbuster debut on Wednesday with its IPO listing at $29 per share. The company raised roughly $6.26 billion and hit the public markets with an implied valuation near $50 billion, making it the year's biggest listing. The Northfield, Illinois-based medical-supplies giant, backed by Blackstone, Carlyle, and Hellman & Friedman, upsized the deal to meet robust institutional demand. Opening trades suggested the stock could gap higher on day one. But investors need to focus on some critica ...